Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Allen

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Blood|October 13, 2016
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosisRikhia Chakraborty, Thomas M Burke, Oliver A Hampton, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Pediatric Blood & Cancer|October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman diseaseStephen J Simko, Huy D Tran, Jeremy Jones, et al.
Hematological Oncology|February 21, 2017
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosisLeomar Y Ballester, Miguel D Cantu, Karen P H Lim, et al.
British Journal of Haematology|November 25, 2020
Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformationNathaniel R Wilson, Hong Fang, Sanam Loghavi, et al.
Pediatric Pulmonology|June 9, 2020
Management of severe pulmonary Langerhans cell histiocytosis in childrenOlive S Eckstein, Jed G Nuchtern, George B Mallory, et al.
Infectious Agents and Cancer|November 21, 2018
Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related diseaseNader Kim El-Mallawany, Jimmy Villiera, William Kamiyango, et al.
HIV Medicine|January 10, 2023
Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and TanzaniaLiane R Campbell, Allison Silverstein, Erin Peckham-Gregory, et al.
Blood Advances|January 4, 2020
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cellsKaren Phaik Har Lim, Paul Milne, Michael Poidinger, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Blood|October 13, 2016
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosisRikhia Chakraborty, Thomas M Burke, Oliver A Hampton, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Pediatric Blood & Cancer|October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman diseaseStephen J Simko, Huy D Tran, Jeremy Jones, et al.
Hematological Oncology|February 21, 2017
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosisLeomar Y Ballester, Miguel D Cantu, Karen P H Lim, et al.
British Journal of Haematology|November 25, 2020
Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformationNathaniel R Wilson, Hong Fang, Sanam Loghavi, et al.
Pediatric Pulmonology|June 9, 2020
Management of severe pulmonary Langerhans cell histiocytosis in childrenOlive S Eckstein, Jed G Nuchtern, George B Mallory, et al.
Infectious Agents and Cancer|November 21, 2018
Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related diseaseNader Kim El-Mallawany, Jimmy Villiera, William Kamiyango, et al.
HIV Medicine|January 10, 2023
Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and TanzaniaLiane R Campbell, Allison Silverstein, Erin Peckham-Gregory, et al.
Blood Advances|January 4, 2020
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cellsKaren Phaik Har Lim, Paul Milne, Michael Poidinger, et al.
Pageof 14